The market in Nordics was valued at USD 7.29 billion in 2025.
The Nordics Infusion Services Market is projected to grow at a CAGR of 11.5%, during the forecast window, to reach USD 17.42 billion in 2033.
Advanced digital scheduling systems and centralized reimbursement models enhance infusion capacity utilization, particularly in Sweden and Denmark where public oncology infrastructure is highly integrated.
Nordic cancer registries report rising prevalence of treatable malignancies, supporting long-term infusion service stability across public hospital networks.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]